Michael I. Okkonen

Dechert LLP

Articles

Results 1 to 5 of 17


The entry into force of the Digital Markets Act kicks off new era of digital regulation in Europe

European Union - October 25 2022 The DMA strengthens EU-level regulation of large digital platforms, termed “gatekeepers”: the main provisions will apply from 2 May 2023, with the…

Laurence Bary, Alec Burnside, Marion Provost, Mélanie Thill-Tayara, Clemens Graf York von Wartenburg

EU Clears Way for New Foreign Subsidies Regime

European Union - August 19 2022 On June 30, 2022, the EU institutions reached a political agreement on the text for the FSR that will give far-reaching powers to the EC to control…

Delphine Strohl, Clemens Graf York von Wartenburg

The Evolving Global Foreign Direct Investment and National Security Review Landscape

European Union, Global - May 30 2022 The national security and foreign direct investment ("FDI") review landscape around the world is evolving rapidly. A pre-pandemic trend of active FDI…

John Bedford, Alec Burnside, Darshak S. Dholakia, Thirith von Döhren, Pavel Dunaev, Isabella Egetenmeir, Betsy Feuerstein, Christopher Field, Sean Geraghty, Hrishikesh N. Hari, Adam Kidane, Zhaohui Li, Brooklynn Moore, Sophie Pelé, Adam C. R. Schmelzer, Kirill Skopchevskiy, Clemens Graf York von Wartenburg, Jeremy B. Zucker

At a glance: pharmaceutical merger review in United Kingdom

United Kingdom - July 1 2021 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in United Kingdom, including review triggers and thresholds.

Alec Burnside, Robert Darwin

In brief: anticompetitive agreements in the pharmaceutical sector in United Kingdom

United Kingdom - July 1 2021 The essential legal considerations surrounding anticompetitive agreements in the pharmaceutical sector in United Kingdom, including the assessment framework and special issues with vertical agreements.

Alec Burnside, Robert Darwin